SFTPB and chronic obstructive pulmonary disease: In a prospective cohort, plasma SP-B levels were found to be significantly higher in patients with COPD compared to controls, and an increase in SP-B over 12 months was correlated with a greater decline in FEV1, suggesting its utility in monitoring disease progression.